一分钟看懂
这是一项关于食管鳞状细胞癌的II 期研究，登记的药物或干预包括Radiotherapy；Programmed Cell Death Protein 1 Inhibitor；Immunonutrition support，当前状态为招募中。登记地点显示中国北京、福建省、Handan、安阳等城市有研究中心记录。是否仍有名额以及是否值得进一步询问，需要向研究中心确认。
药物或干预
Radiotherapy；Programmed Cell Death Protein 1 Inhibitor；Immunonutrition support · II 期
登记条件中文摘要
年龄范围：18岁至80岁
登记的基本范围为不限性别，年龄18岁至80岁；以下仅摘录8项专业入选条件，需结合英文原文并由研究团队确认。
登记记录列出8项主要排除条件，具体医学含义需结合英文原文并由研究团队确认。
中国哪些地方有记录
以下地点来自登记信息，不代表此刻仍有名额；请向研究中心确认最新情况。
- Department of Radiation Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College · 北京
- Department of Radiation Oncology，Clinical Oncology School of Fujian Medical University，Fujian Cancer Hospital · 福建省
- Department of Oncology, Affiliated Hospital, Hebei University of Engineering · Handan
- Department 1st of Radiation Oncology, Anyang Tumor Hospital · 安阳
- Department of Radiation Oncology the first affiliated hospital of Xinxiang Medical University · 新乡
- Department of Radiation Oncology, General Hospital of Ningxia Medical University · 银川
- Department of Radiation Oncology，Fei County People's Hospital · Feixian
- Department of Radiation Oncology, Affiliated hospital of Jining Medical University · 济宁
- Tianjin Medical University Cancer Institute & Hospital · 天津
- Taizhou hospital of Wenzhou Medical University · 台州
入选条件原文摘录
以下为摘录，请打开原始登记查看完整入排标准。
- 1. Aged 18 years or order.
- 2. Diagnosed with locally advanced or early stage esophageal squamous cell carcinoma by pathological examinations of the primary lesion and imaging examinations, which are not resectable.
- 3. Confirmed to be unresectable and unable to tolerate synchronous chemoradiotherapy by multidisciplinary consultation, and has not undergone systemic drug therapy in the past.
- 4. PD-L1 tumor proportion score or combined positive score of ≥1%.
- 5. At least one measurable lesion on imaging according to the Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1.
- 6. An Eastern Cooperative Oncology Group (ECOG) performance status score of 0 -2.
- 7. Expected survival time of more than three months.
- 8. Adequate organ function defined as the following laboratory indicators:
联系前需要确认
请继续确认中心是否启动、疾病分型、既往治疗、检查费用和知情同意安排。
查看登记信息
登记号：NCT06342167；登记信息更新于 2026-10-07；本站同步于 2026-10-08，中国中心当前名额未经人工确认。